**Correction to: Mol Cancer (2019) 18:43** Fig. 1**a.** Migration and invasion ability of parental and resistant CRC cells were assessed by Transwell assay (replace Fig. 1e). **b.** The immunofluorescence analysis of nuclear foci for γ-H~2~AX expression induced by oxaliplatin in parental and resistant cells after 24 h oxaliplatin exposure. Scale bars, 10 μm (replace Fig. 1j). **c.** Migration and invasion ability of HCT116OxR cells transfected with Lv-128 and Ctrl were assessed by Transwell assay (replace Fig. 2f). **d.** Migration and invasion ability of HCT116OxR cells after incubated with indicated factors for 48 h were assessed by Transwell assays (replace Fig. 5d). **e.** Migration and invasion ability of Lv-128 transfected HCT116OxR cells in different conditions were assessed by Transwell assays (replace Fig. 6g). **f.** Migration and invasion ability of HT29OxR cells after incubated with indicated factors for 48 h were assessed by Transwell assays (replace Fig. S4D)
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Following the publication of the original article \[[@CR1]\], the authors noticed some incorrect information are shown. Inverted-microscope pictures of transwell assay were placed in the mistaken figure inadvertently and the fluorescence-microscope picture was mistakenly switched. The correct version of figure is given in Fig. [1](#Fig1){ref-type="fig"}. The authors apologize for any inconvenience caused, and these corrections do not affect the findings or conclusions of this research.
